A detailed history of Tealwood Asset Management Inc transactions in Exelixis, Inc. stock. As of the latest transaction made, Tealwood Asset Management Inc holds 59,466 shares of EXEL stock, worth $1.31 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
59,466
Previous 60,282 1.35%
Holding current value
$1.31 Million
Previous $1.45 Million 2.42%
% of portfolio
0.64%
Previous 0.69%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

SELL
$20.17 - $23.93 $16,458 - $19,526
-816 Reduced 1.35%
59,466 $1.41 Million
Q4 2023

Jan 08, 2024

SELL
$19.25 - $24.13 $34,284 - $42,975
-1,781 Reduced 2.87%
60,282 $1.45 Million
Q3 2023

Nov 08, 2023

SELL
$19.04 - $22.74 $29,473 - $35,201
-1,548 Reduced 2.43%
62,063 $1.36 Million
Q2 2023

Jul 26, 2023

SELL
$18.17 - $20.48 $14,626 - $16,486
-805 Reduced 1.25%
63,611 $1.22 Million
Q1 2023

Apr 12, 2023

BUY
$16.3 - $19.41 $589,929 - $702,486
36,192 Added 128.23%
64,416 $1.25 Million
Q4 2022

Jan 17, 2023

SELL
$14.96 - $17.39 $454,619 - $528,464
-30,389 Reduced 51.85%
28,224 $453,000
Q3 2022

Nov 16, 2022

SELL
$15.68 - $22.27 $4,061 - $5,767
-259 Reduced 0.44%
58,613 $919,000
Q2 2022

Jul 20, 2022

SELL
$17.44 - $23.16 $21,677 - $28,787
-1,243 Reduced 2.07%
58,872 $1.23 Million
Q1 2022

May 02, 2022

BUY
$17.03 - $22.67 $49,931 - $66,468
2,932 Added 5.13%
60,115 $1.36 Million
Q4 2021

Mar 15, 2022

SELL
$15.84 - $21.88 $88,593 - $122,374
-5,593 Reduced 8.91%
57,183 $1.05 Million
Q3 2021

Dec 02, 2021

SELL
$16.3 - $21.14 $81,337 - $105,488
-4,990 Reduced 7.36%
62,776 $1.33 Million
Q1 2021

Jun 21, 2021

SELL
$20.53 - $25.22 $1,416 - $1,740
-69 Reduced 0.1%
67,766 $1.53 Million
Q4 2020

Mar 09, 2021

BUY
$18.39 - $24.8 $526,910 - $710,569
28,652 Added 73.12%
67,835 $1.36 Million
Q3 2020

Dec 14, 2020

BUY
$20.67 - $26.94 $2,129 - $2,774
103 Added 0.26%
39,183 $958,000
Q2 2020

Aug 03, 2020

SELL
$16.46 - $27.42 $1.49 Million - $2.48 Million
-90,527 Reduced 69.85%
39,080 $928,000
Q1 2020

May 13, 2020

BUY
$14.46 - $21.8 $112,195 - $169,146
7,759 Added 6.37%
129,607 $2.23 Million
Q4 2019

Jan 16, 2020

SELL
$15.15 - $18.89 $231,507 - $288,658
-15,281 Reduced 11.14%
121,848 $2.15 Million
Q3 2019

Oct 23, 2019

SELL
$17.68 - $22.65 $39,214 - $50,237
-2,218 Reduced 1.59%
137,129 $2.43 Million
Q2 2019

Aug 06, 2019

SELL
$18.93 - $24.75 $9,465 - $12,375
-500 Reduced 0.36%
139,347 $2.98 Million
Q1 2019

Apr 15, 2019

BUY
$19.6 - $24.76 $235,376 - $297,342
12,009 Added 9.39%
139,847 $3.33 Million
Q4 2018

Jan 15, 2019

SELL
$13.65 - $21.8 $375,893 - $600,328
-27,538 Reduced 17.72%
127,838 $2.52 Million
Q3 2018

Oct 16, 2018

SELL
$15.87 - $22.4 $36,992 - $52,214
-2,331 Reduced 1.48%
155,376 $2.75 Million
Q2 2018

Jul 25, 2018

BUY
$18.56 - $22.45 $2.93 Million - $3.54 Million
157,707 New
157,707 $3.39 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $7.07B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Tealwood Asset Management Inc Portfolio

Follow Tealwood Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tealwood Asset Management Inc with notifications on news.